EP3283649A4 - Procédé et système pour la caractérisation, le diagnostic et le traitement dérivés du microbiome de pathologies cardiovasculaires - Google Patents

Procédé et système pour la caractérisation, le diagnostic et le traitement dérivés du microbiome de pathologies cardiovasculaires Download PDF

Info

Publication number
EP3283649A4
EP3283649A4 EP16780655.3A EP16780655A EP3283649A4 EP 3283649 A4 EP3283649 A4 EP 3283649A4 EP 16780655 A EP16780655 A EP 16780655A EP 3283649 A4 EP3283649 A4 EP 3283649A4
Authority
EP
European Patent Office
Prior art keywords
microbiome
therapeutics
diagnostics
cardiovascular disease
disease conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16780655.3A
Other languages
German (de)
English (en)
Other versions
EP3283649A1 (fr
Inventor
Zachary APTE
Daniel Almonacid
Jessica RICHMAN
Siavosh Rezvan BEHBAHANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psomagen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3283649A1 publication Critical patent/EP3283649A1/fr
Publication of EP3283649A4 publication Critical patent/EP3283649A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Biophysics (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Pathology (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)
  • Primary Health Care (AREA)
  • Evolutionary Computation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP16780655.3A 2015-04-14 2016-04-13 Procédé et système pour la caractérisation, le diagnostic et le traitement dérivés du microbiome de pathologies cardiovasculaires Withdrawn EP3283649A4 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562147364P 2015-04-14 2015-04-14
US201562147092P 2015-04-14 2015-04-14
US201562147337P 2015-04-14 2015-04-14
US201562147304P 2015-04-14 2015-04-14
US201562147217P 2015-04-14 2015-04-14
PCT/US2016/027341 WO2016168336A1 (fr) 2015-04-14 2016-04-13 Procédé et système pour la caractérisation, le diagnostic et le traitement dérivés du microbiome de pathologies cardiovasculaires

Publications (2)

Publication Number Publication Date
EP3283649A1 EP3283649A1 (fr) 2018-02-21
EP3283649A4 true EP3283649A4 (fr) 2019-03-20

Family

ID=57127197

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16780655.3A Withdrawn EP3283649A4 (fr) 2015-04-14 2016-04-13 Procédé et système pour la caractérisation, le diagnostic et le traitement dérivés du microbiome de pathologies cardiovasculaires

Country Status (4)

Country Link
EP (1) EP3283649A4 (fr)
CN (1) CN107710205A (fr)
AU (2) AU2016248115A1 (fr)
WO (1) WO2016168336A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016168370A1 (fr) * 2015-04-14 2016-10-20 uBiome, Inc. Procédé et système de diagnostics et de traitements dérivés du microbiome pour des dysfonctionnements du système endocrinien
JP2021516330A (ja) * 2018-03-16 2021-07-01 プソマーゲン， インコーポレイテッドＰｓｏｍａｇｅｎ， Ｉｎｃ． バイオインフォマティクスアプローチに基づく、診断及び治療を含む、代謝関連状態の特徴解析のための方法及びシステム
CN109920478B (zh) * 2019-03-07 2020-12-08 中南大学 一种基于相似性和低秩矩阵填充的微生物-疾病关系预测方法
CN111020038B (zh) * 2019-12-30 2023-11-10 南方医科大学南方医院 用于诊断心脏瓣膜钙化的肠道微生物、引物组及应用
CN112716504B (zh) * 2020-12-22 2023-12-15 沈阳东软智能医疗科技研究院有限公司 心电数据的处理方法、装置、存储介质和电子设备
CN112509700A (zh) * 2021-02-05 2021-03-16 中国医学科学院阜外医院 稳定型冠心病的风险预测方法及装置
CN115851910B (zh) * 2022-11-23 2024-06-18 湖州市中心医院 一种诊断或预测冠心病的标志物、系统和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130052172A1 (en) * 2011-08-26 2013-02-28 John Edward Baker Methods for diagnosing and treating cardiac defects
WO2014053608A1 (fr) * 2012-10-03 2014-04-10 Metabogen Ab Identification d'une personne ayant un risque d'athérosclérose et de maladies associées par le microbiome intestinal de la personne et prévention de telles maladies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
US20100191141A1 (en) * 2009-01-27 2010-07-29 Peter Aberg Method and apparatus for diagnosing a diseased condition in tissue of a subject
US20120129794A1 (en) * 2009-07-24 2012-05-24 Dowd Scot E Apparati, methods, and compositions for universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
CN102762743A (zh) * 2009-12-09 2012-10-31 阿维埃尔公司 用于心血管疾病的诊断和分类的生物标记物检验
WO2012050513A1 (fr) * 2010-10-11 2012-04-19 Baeckhed Fredrik Méthode pour identifier un risque de maladie cardiovasculaire par analyse d'un microbiote oral
JP6637885B2 (ja) * 2013-07-21 2020-01-29 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム
AU2015209718B2 (en) * 2014-01-25 2021-03-25 Macrogen Inc. Method and system for microbiome analysis
CN104032016B (zh) * 2014-06-12 2016-03-30 山东农业大学 一种鸡肠炎沙门氏菌感染相关microRNA的检测方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130052172A1 (en) * 2011-08-26 2013-02-28 John Edward Baker Methods for diagnosing and treating cardiac defects
WO2014053608A1 (fr) * 2012-10-03 2014-04-10 Metabogen Ab Identification d'une personne ayant un risque d'athérosclérose et de maladies associées par le microbiome intestinal de la personne et prévention de telles maladies

Also Published As

Publication number Publication date
WO2016168336A1 (fr) 2016-10-20
EP3283649A1 (fr) 2018-02-21
AU2016248115A1 (en) 2017-11-09
CN107710205A (zh) 2018-02-16
AU2022203346A1 (en) 2022-06-09

Similar Documents

Publication Publication Date Title
EP3347495A4 (fr) Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé gastro-intestinale
EP3209803A4 (fr) Procédé et système de diagnostic et de thérapie fondés sur le microbiome
EP3121613A4 (fr) Procédé d'estimation de dégradation, système d'estimation de dégradation, et programme d'estimation de dégradation
EP3280302A4 (fr) Système, procédé et appareil d'infusion à froid
EP3347496A4 (fr) Méthode et système de diagnostics dérivés du microbiome et traitements thérapeutiques pour la santé bucco-dentaire
EP3206582A4 (fr) Appareil, système et procédés pour analyse d'urine
EP3321629A4 (fr) Procédé de détermination d'étage, appareil associé et système
EP3352428A4 (fr) Procédé, appareil et système de partage de charge
EP3091786A4 (fr) Appareil, procédé et système de sélection de cellules
EP3239741A4 (fr) Appareil de calcul d'état, procédé de calcul d'état, et programme de calcul d'état
EP3283649A4 (fr) Procédé et système pour la caractérisation, le diagnostic et le traitement dérivés du microbiome de pathologies cardiovasculaires
EP3346912A4 (fr) Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé cérébro-carniofaciale
EP3283086A4 (fr) Procédé et système de diagnostic et de traitement dérivés du microbiome pour des pathologies associées aux caractéristiques fonctionnelles du microbiome
EP3128385A4 (fr) Système d'évaluation des risques pour système à processus, programme d'évaluation des risques et procédé d'évaluation des risques
EP3175916A4 (fr) Procédé pour produire un catalyseur de type c ur-écorce
EP3270096A4 (fr) Système de mesure, procédé de mesure et programme de mesure
EP3162584A4 (fr) Appareil de formation d'image, système de formation d'image et procédé de formation d'image
EP3283084A4 (fr) Procédé et système de caractérisation, de diagnostics et de traitements dérivés du microbiome pour des dermatoses
EP3172892A4 (fr) Appareil d'imagerie, appareil d'imagerie/affichage et procédé de commande associé
EP3240231A4 (fr) Système de visualisation de configuration en nuage, procédé de visualisation de configuration en nuage, et programme de visualisation de configuration en nuage
EP3222769A4 (fr) Procédé de commande et système de commande pour aide au lavage, et aide au lavage
EP3270097A4 (fr) Système de mesure, procédé de mesure et programme de mesure
EP3216521A4 (fr) Complexe transporteur-nanoparticule, son procédé de préparation et catalyseur comprenant celui-ci
EP3111700A4 (fr) Système et procédé de transfert spécifique à un ue
EP3163410A4 (fr) Système de mesure de ligne de visée, procédé de mesure de ligne de visée, et programme

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171020

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G16H 50/50 20180101ALI20181109BHEP

Ipc: A61K 35/74 20150101ALI20181109BHEP

Ipc: C12Q 1/68 20180101ALI20181109BHEP

Ipc: C12Q 1/6883 20180101ALI20181109BHEP

Ipc: C12Q 1/689 20180101ALI20181109BHEP

Ipc: G06F 19/18 20110101AFI20181109BHEP

Ipc: G06F 19/24 20110101ALI20181109BHEP

Ipc: G16H 50/70 20180101ALI20181109BHEP

Ipc: G16H 50/20 20180101ALI20181109BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20190218

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/48 20060101ALI20190306BHEP

Ipc: G01N 33/569 20060101ALI20190306BHEP

Ipc: C12Q 1/68 20180101AFI20190306BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190918

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

D18D Application deemed to be withdrawn (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230929

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

R18D Application deemed to be withdrawn (corrected)

Effective date: 20240210